|
Saturday, June 27, 2009 |
|
|
|
|
7:00 AM – 6:00 PM |
Registration |
|
|
|
|
7:30 AM – 8:00 AM |
Education Course: Coffee and Breakfast
|
|
|
|
|
8:00 AM – 11:45 AM |
Education Course |
|
|
Session 1: Epigenetic
Mechanisms
|
|
|
(Separate registration required) |
|
|
Organized by the Education Committee, Chairperson, Tacey E. White, GlaxoSmithKline |
|
|
|
|
8:00 AM – 8:10 AM |
Welcome |
|
|
Christina D. Chambers, Teratology Society President |
|
|
|
|
8:10 AM – 8:25 AM |
Narsingh Agnish Fellowship |
| |
Richard M. Hoar |
|
|
|
|
8:25 AM – 8:30 AM |
Introduction and Course Overview |
|
|
Speaker: Education Committee
Chairperson, Tacey E. White, GlaxoSmithKline
|
|
|
|
|
8:30 AM – 9:15 AM |
Chromatin Structure and Histone Modifications |
|
|
Speaker: Sarah Kimmins, McGill University |
|
|
|
|
9:15 AM – 10:00 AM |
DNA Methylation |
|
|
Speaker: Jacquetta
M. Trasler, McGill University |
|
|
|
|
10:00 AM – 10:15 AM |
Break |
|
|
|
|
10:15 AM – 11:00 AM |
Imprinting and X-Inactivation |
|
|
Speaker: Martha
Susiarjo, University of Pennsylvania Medical School |
|
|
|
|
11:00 AM – 11:45 AM |
Epigenetics and the Developmental Origins Hypothesis |
|
|
Speaker: Robert
A. Waterland, Baylor College of Medicine |
|
|
|
|
11:45 AM – 1:45 PM |
Lunch – on your own
|
|
|
|
|
12:00 NOON – 12:30 PM |
Register of Fetal Morphologists: Web Based Training Program, Practical Assessment and Continuing Professional Development |
|
|
Speaker: Julian M. French, AstraZeneca
|
|
|
|
|
1:45 PM – 5:30 PM |
Education Course |
|
|
Session 2: Adult Disease
Outcomes of Developmental Programming
|
|
|
(Separate registration required) |
|
|
Organized by the Education Committee, Chairperson, Tacey E. White, GlaxoSmithKline |
|
|
|
|
1:45 PM – 2:15 PM |
Session 2 Introduction: Historical
Perspectives of Developmental Origins of Health and Disease (Barker
Hypothesis, Thrifty Phenotype, Plasticity)
|
|
|
Speaker: Jerry
J. Heindel, National Institute of Environmental Health Sciences |
|
|
|
|
2:15 PM – 3:00 PM |
Metabolic Syndrome (Obesity, Diabetes, Dyslipidemia) |
|
|
Speaker: Laura A. Cox, Southwest Foundation for Biomedical Research |
|
|
|
|
3:00 PM – 3:15 PM |
Break |
|
|
|
|
3:15 PM – 4:00 PM |
Cardiovascular and Kidney Function |
|
|
Speaker: Robert
G. Ellis-Hutchings, The Dow Chemical Company
|
| |
|
|
4:00 PM – 4:45 PM |
Neurobehavioral / Psychiatric Function |
|
|
Speaker: Ezra
S. Susser, Columbia University
|
|
|
|
|
4:45 PM – 5:30 PM |
Cancer |
|
|
Speaker: Gail
S. Prins, University of Illinois, Chicago
|
|
|
|
|
6:30 PM – 9:30 PM |
Council 1B Meeting and Committee Reports |
|
|
|
|
|
|
Information
(2.4 MB)